Suparma Tbk Valuation
| SPMA Stock | IDR 266.00 14.00 5.00% |
At this time, the company appears to be overvalued. Suparma Tbk has a current Real Value of 231.0 per share. The regular price of the company is 266.0. Our model measures the value of Suparma Tbk from inspecting the company fundamentals such as Operating Margin of 0.16 %, shares outstanding of 3.15 B, and Return On Equity of 0.19 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Suparma Tbk's price fluctuation is very steady at this time. Calculation of the real value of Suparma Tbk is based on 3 months time horizon. Increasing Suparma Tbk's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Suparma Tbk's intrinsic value may or may not be the same as its current market price of 266.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 266.0 | Real 231.0 | Hype 266.0 | Naive 260.5 |
The intrinsic value of Suparma Tbk's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Suparma Tbk's stock price.
Estimating the potential upside or downside of Suparma Tbk helps investors to forecast how Suparma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Suparma Tbk more accurately as focusing exclusively on Suparma Tbk's fundamentals will not take into account other important factors: Suparma Tbk Total Value Analysis
Suparma Tbk is at this time forecasted to have takeover price of 1.45 T with market capitalization of 1.59 T, debt of 308.5 B, and cash on hands of 137.63 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Suparma Tbk fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.45 T | 1.59 T | 308.5 B | 137.63 B |
Suparma Tbk Investor Information
About 92.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 128.42. Suparma Tbk last dividend was issued on the 16th of June 2021. The entity had 113:100 split on the 15th of June 2022. Suparma Tbk is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Suparma Tbk Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Suparma Tbk has an asset utilization ratio of 101.76 percent. This suggests that the Company is making 1.02 for each dollar of assets. An increasing asset utilization means that Suparma Tbk is more efficient with each dollar of assets it utilizes for everyday operations.Suparma Tbk Ownership Allocation
Suparma Tbk shows a total of 3.15 Billion outstanding shares. Suparma Tbk has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 92.37 % of Suparma Tbk outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Suparma Tbk Profitability Analysis
The company reported the revenue of 2.79 T. Net Income was 294.33 B with profit before overhead, payroll, taxes, and interest of 582.39 B.About Suparma Tbk Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Suparma Tbk. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Suparma Tbk based exclusively on its fundamental and basic technical indicators. By analyzing Suparma Tbk's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Suparma Tbk's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Suparma Tbk. We calculate exposure to Suparma Tbk's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Suparma Tbk's related companies.PT Suparma Tbk manufactures and sells paper and packaging paper products in Indonesia. PT Suparma Tbk was founded in 1976 and is headquartered in Surabaya, Indonesia. Suparma Tbk operates under Paper Paper Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 734 people.
8 Steps to conduct Suparma Tbk's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Suparma Tbk's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Suparma Tbk's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Suparma Tbk's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Suparma Tbk's revenue streams: Identify Suparma Tbk's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Suparma Tbk's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Suparma Tbk's growth potential: Evaluate Suparma Tbk's management, business model, and growth potential.
- Determine Suparma Tbk's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Suparma Tbk's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Suparma Stock
Suparma Tbk financial ratios help investors to determine whether Suparma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suparma with respect to the benefits of owning Suparma Tbk security.